Bio Techne | TECH - Operating Expenses

Stock Price
43.31
Daily Change
-1.43 -3.20%
Monthly
-24.49%
Yearly
-11.88%
Q2 Forecast
47.36

Bio Techne reported $235.92M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Illumina USD 852M 51M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Merck EUR 4.78B 669M Dec/2025
Mettler Toledo International USD 713.2M 64.61M Mar/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Repligen USD 174.27M 3.67M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Standard Biotools USD 45.72M 2.7M Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Waters USD 1.12B 457.15M Mar/2026